Skip to search boxSkip to navigationSkip to main content

Transcriptional and Posttranslational Regulation of eNOS in the Endothelium

*Corresponding author for this work
Scholary Output:
Chapter in Book/Report/Conference proceeding
Chapter

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Nitric oxide (NO) is a highly reactive free radical gas and these unique properties have been adapted for a surprising number of biological roles. In neurons, NO functions as a neurotransmitter; in immune cells, NO contributes to host defense; and in endothelial cells, NO is a major regulator of blood vessel homeostasis. In the vasculature, NO is synthesized on demand by a specific enzyme, endothelial nitric oxide synthase (eNOS) that is uniquely expressed in the endothelial cells that form the interface between the circulating blood and the various tissues of the body. NO regulates endothelial and blood vessel function via two distinct pathways, the activation of soluble guanylate cyclase and cGMP-dependent signaling and the S-nitrosylation of proteins with reactive thiols (S-nitrosylation). The chemical properties of NO also serve to reduce oxidation and regulate mitochondrial function. Reduced synthesis and/or compromised biological activity of NO precede the development of cardiovascular disease and this has generated a high level of interest in the mechanisms controlling the synthesis and fate of NO in the endothelium. The amount of NO produced results from the expression level of eNOS, which is regulated at the transcriptional and posttranscriptional levels as well as the acute posttranslational regulation of eNOS. The goal of this chapter is to highlight and integrate past and current knowledge of the mechanisms regulating eNOS expression in the endothelium and the posttranslational mechanisms regulating eNOS activity in both health and disease.

Publication Information

Output type

Scholary Output:
Chapter in Book/Report/Conference proceeding
Chapter

Original language

English (US)

Pages from-to (Number of pages)

Pages 29-64 (36 pages)

Publication milestones

  • Published - 2016

Publication status

Published - 2016

Publisher

Academic Press Inc., United States

Publication series

  • Publication series name: Advances in Pharmacology
    ISSN (Print): 1054-3589
    ISSN (Electronic): 1557-8925
    Volume: 77
9780128043967

Publication IDs

  • Scopus: 84969206859
  • PubMed: 27451094

Host publication title

Endothelium, 2016

Host publication editors

  • Raouf A. Khalil

Publication metrics

Metrics

Fractional count
1
Fractional count
1
Fractional count
1
Fractional count
1
SciVal
FWCI
0.76
SciVal
Author count
1
SciVal
citations
10
SciVal
Paper percentile
72
Scopus
citations

PlumX, opens in new tab

Captures
24
Citation count
29

Funding Details

FunderFunding number
NHLBI
R01HL124773